General Information of the Compound
| Compound ID |
CP0667774
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(3,5-dimethoxyphenyl)-3-(1-(2-methoxyethyl)-1H-pyrazol-4-yl)-N-((3-methylisoxazol-5-yl)methyl)quinoxalin-6-amine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H28N6O4
|
||||||||||||||||||
| Molecular Weight |
500.559
|
||||||||||||||||||
| Canonical SMILES |
COCCn1cc(-c2cnc3ccc(N(Cc4cc(C)no4)c4cc(OC)cc(OC)c4)cc3n2)cn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H28N6O4/c1-18-9-24(37-31-18)17-33(21-10-22(35-3)13-23(11-21)36-4)20-5-6-25-26(12-20)30-27(15-28-25)19-14-29-32(16-19)7-8-34-2/h5-6,9-16H,7-8,17H2,1-4H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
SYVJHJOWIMUQMA-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01091, Fibroblast growth factor receptor 1
Protein ID: PT01411, Fibroblast growth factor receptor 3
Protein ID: PT01204, Receptor-type tyrosine-protein kinase FLT3
Protein ID: PT00864, Vascular endothelial growth factor receptor 2